ANTH
Anthera Pharmaceuticals, Inc.
ANTH
ANTH
Delisted
ANTH was delisted on the 27th of June, 2018.
72 hedge funds and large institutions have $83M invested in Anthera Pharmaceuticals, Inc. in 2016 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 28 increasing their positions, 21 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
17% less capital invested
Capital invested by funds: $99.4M → $83M (-$16.4M)
70% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 20
Holders
72
Holding in Top 10
2
Calls
$357K
Puts
$194K
Top Buyers
| 1 | +$6.07M | |
| 2 | +$1.81M | |
| 3 | +$1.74M | |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
+$720K |
| 5 |
RPAM
Rhenman & Partners Asset Management
Stockholm,
Sweden
|
+$670K |
Top Sellers
| 1 | -$1.61M | |
| 2 | -$1.25M | |
| 3 | -$1.08M | |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
-$921K |
| 5 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
-$650K |